Calcitonin News and Research

RSS

Calcitonin is a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body.

Experts offer insights into new class of migraine medications

As research continues to show progress towards minimizing the effects of headache disorders on patients' lives, Practical Neurology gathered insights from experts in the field at The American Headache Society 61st Annual Scientific Meeting this year, where new data looking at a range of approaches from nerve stimulation to monoclonal antibodies and neuromodulation devices revealed advancements in migraine treatment.

16 Sep 2019

Melatonin promises to help reduce bone loss in space flight

New research suggests that the problem of bone loss caused by microgravity conditions in space flight may be successfully treated using the time-tested drug melatonin. Melatonin increases the level of calcitonin in bone, which suppresses the bone-destroying activity of osteoclastic cells and helps maintain bone density.

4 Sep 2019

New AAN guidelines includes recommendations for treatment of migraine in children, teens

For children and teens with migraine, the pain and symptoms that accompany migraine attacks can be debilitating, resulting in missed school days, absence from social or sporting events, and affected home activities.

14 Aug 2019

Research may help explain why migraine is more common in women than men

Low doses of a peptide known for decades to be involved in migraine trigger pain responses in female but not male rodents, according to a new research published in JNeurosci.

From Society for Neuroscience 9 Apr 2019

Researchers find new class of blood pressure-regulating peptides in vampire bat venom

Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work.

17 Jan 2019

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVY injection for the preventive treatment of migraine in adults.

17 Sep 2018

Research uncovers miscarriage cause, identifies potential targets for treatment

Tragic miscarriages for a couple have led to a discovery with potentially broad implications for future disease treatments, according to a team of researchers at the University of North Carolina School of Medicine. They identified a previously undiscovered gene mutation underlying hydrops fetalis – a fatal condition to fetuses due to fluid buildup in the space between organs.

16 Aug 2018

Scientists examine how specific eating patterns could help fight cancer and obesity

What we eat plays a significant role in our health. The Experimental Biology 2018 meeting (EB 2018) will showcase new research into how diet could be used to fight cancer and how specific eating patterns can encourage weight loss.

23 Apr 2018

New drug for migraine in the pipeline

According to a pilot study results released yesterday (17th of April 2018), a new drug may help provide relief to people with migraine that is unsuccessfully treated with the currently available drugs.

18 Apr 2018

New findings about fruit fly's body temperature rhythms may help people sleep better

In findings that one day may help people sleep better, scientists have uncovered the first molecular evidence that two anciently conserved proteins in the brains of insects and mammals share a common biological ancestry as regulators of body temperature rhythms crucial to metabolism and sleep.

13 Feb 2018

New drugs Erenumab and Fremanezumab show promise for migraine

Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well.

30 Nov 2017

New immunotherapy study shows positive results in chronic migraine sufferers

A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic migraine sufferers experienced headaches.

30 Nov 2017

$Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women$

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Women who took a drug holiday (temporary or permanent discontinuation of a medicine) from using bisphosphonates for more than two years have a significantly higher risk of a hip fracture compared to others who continued their treatment, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Calcitonin News and Research

Further Reading

Experts offer insights into new class of migraine medications

Melatonin promises to help reduce bone loss in space flight

New AAN guidelines includes recommendations for treatment of migraine in children, teens

Research may help explain why migraine is more common in women than men

Researchers find new class of blood pressure-regulating peptides in vampire bat venom

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Research uncovers miscarriage cause, identifies potential targets for treatment

Scientists examine how specific eating patterns could help fight cancer and obesity

New drug for migraine in the pipeline

New findings about fruit fly's body temperature rhythms may help people sleep better

New drugs Erenumab and Fremanezumab show promise for migraine

New immunotherapy study shows positive results in chronic migraine sufferers

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

New monoclonal antibody shows efficacy in chronic migraine patients with medication overuse

Novartis announces data revealing efficacy of new monoclonal antibody therapy in preventing migraine

Cluster headaches: searching for effective therapies

PCT screening could be promising tool to help shorten hospital stays, reduce costs for sepsis patients

Scientists devise new radiation-free probe for imaging molecules in the brain

Snapping at new biotech breakthroughs with Gator Pro

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

Latest News

Neuroscience eBook